240 related articles for article (PubMed ID: 19159248)
1. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.
Patil ML; Zhang M; Taratula O; Garbuzenko OB; He H; Minko T
Biomacromolecules; 2009 Feb; 10(2):258-66. PubMed ID: 19159248
[TBL] [Abstract][Full Text] [Related]
2. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.
Patil ML; Zhang M; Betigeri S; Taratula O; He H; Minko T
Bioconjug Chem; 2008 Jul; 19(7):1396-403. PubMed ID: 18576676
[TBL] [Abstract][Full Text] [Related]
3. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
Golkar N; Samani SM; Tamaddon AM
Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
[TBL] [Abstract][Full Text] [Related]
4. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.
Taratula O; Garbuzenko OB; Kirkpatrick P; Pandya I; Savla R; Pozharov VP; He H; Minko T
J Control Release; 2009 Dec; 140(3):284-93. PubMed ID: 19567257
[TBL] [Abstract][Full Text] [Related]
5. LHRH-targeted nanoparticles for cancer therapeutics.
Minko T; Patil ML; Zhang M; Khandare JJ; Saad M; Chandna P; Taratula O
Methods Mol Biol; 2010; 624():281-94. PubMed ID: 20217603
[TBL] [Abstract][Full Text] [Related]
6. Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Parsian M; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
Int J Pharm; 2016 Dec; 515(1-2):104-113. PubMed ID: 27725272
[TBL] [Abstract][Full Text] [Related]
7. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
8. Effects of the surface charge of polyamidoamine dendrimers on cellular exocytosis and the exocytosis mechanism in multidrug-resistant breast cancer cells.
Zhang J; Li M; Wang M; Xu H; Wang Z; Li Y; Ding B; Gao J
J Nanobiotechnology; 2021 May; 19(1):135. PubMed ID: 33980270
[TBL] [Abstract][Full Text] [Related]
9. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.
Kang H; DeLong R; Fisher MH; Juliano RL
Pharm Res; 2005 Dec; 22(12):2099-106. PubMed ID: 16184444
[TBL] [Abstract][Full Text] [Related]
10. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
Xu L; Yeudall WA; Yang H
Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of PAMAM dendrimers for cellular delivery of siRNA.
Waite CL; Sparks SM; Uhrich KE; Roth CM
BMC Biotechnol; 2009 Apr; 9():38. PubMed ID: 19389227
[TBL] [Abstract][Full Text] [Related]
12. Functionalization of Halloysite Nanotubes via Grafting of Dendrimer for Efficient Intracellular Delivery of siRNA.
Long Z; Wu YP; Gao HY; Li YF; He RR; Liu M
Bioconjug Chem; 2018 Aug; 29(8):2606-2618. PubMed ID: 29947505
[TBL] [Abstract][Full Text] [Related]
13. The effect of pH on PAMAM dendrimer-siRNA complexation: endosomal considerations as determined by molecular dynamics simulation.
Ouyang D; Zhang H; Parekh HS; Smith SC
Biophys Chem; 2011 Oct; 158(2-3):126-33. PubMed ID: 21752532
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells.
Ghaffari M; Dehghan G; Baradaran B; Zarebkohan A; Mansoori B; Soleymani J; Ezzati Nazhad Dolatabadi J; Hamblin MR
Colloids Surf B Biointerfaces; 2020 Apr; 188():110762. PubMed ID: 31911391
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.
Taratula O; Garbuzenko O; Savla R; Wang YA; He H; Minko T
Curr Drug Deliv; 2011 Jan; 8(1):59-69. PubMed ID: 21034421
[TBL] [Abstract][Full Text] [Related]
16. Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency.
Lee JH; Lim YB; Choi JS; Lee Y; Kim TI; Kim HJ; Yoon JK; Kim K; Park JS
Bioconjug Chem; 2003; 14(6):1214-21. PubMed ID: 14624638
[TBL] [Abstract][Full Text] [Related]
17. Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.
Shah V; Taratula O; Garbuzenko OB; Taratula OR; Rodriguez-Rodriguez L; Minko T
Clin Cancer Res; 2013 Nov; 19(22):6193-204. PubMed ID: 24036854
[TBL] [Abstract][Full Text] [Related]
18. Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells.
Lv T; Yu T; Fang Y; Zhang S; Jiang M; Zhang H; Zhang Y; Li Z; Chen H; Gao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():182-190. PubMed ID: 28415453
[TBL] [Abstract][Full Text] [Related]
19. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer cells with biotin-dendrimer conjugates.
Yang W; Cheng Y; Xu T; Wang X; Wen LP
Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]